211 related articles for article (PubMed ID: 23379657)
1. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
Bartus C; William Hanke C; Daro-Kaftan E
Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
[TBL] [Abstract][Full Text] [Related]
2. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
[TBL] [Abstract][Full Text] [Related]
3. The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies.
Burgess C
J Drugs Dermatol; 2011 Sep; 10(9):1001-6. PubMed ID: 22052268
[TBL] [Abstract][Full Text] [Related]
4. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
Vleggaar D; Fitzgerald R; Lorenc ZP
J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
[TBL] [Abstract][Full Text] [Related]
5. Consensus recommendations on the use of injectable poly-L-lactic acid for facial and nonfacial volumization.
Vleggaar D; Fitzgerald R; Lorenc ZP; Andrews JT; Butterwick K; Comstock J; Hanke CW; O'Daniel TG; Palm MD; Roberts WE; Sadick N; Teller CF
J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s44-51. PubMed ID: 24719078
[TBL] [Abstract][Full Text] [Related]
6. Techniques for the optimization of facial and nonfacial volumization with injectable poly-l-lactic acid.
Lorenc ZP
Aesthetic Plast Surg; 2012 Oct; 36(5):1222-9. PubMed ID: 22926148
[TBL] [Abstract][Full Text] [Related]
7. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume.
Schierle CF; Casas LA
Aesthet Surg J; 2011 Jan; 31(1):95-109. PubMed ID: 21239677
[TBL] [Abstract][Full Text] [Related]
8. Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience.
Butterwick K; Lowe NJ
J Am Acad Dermatol; 2009 Aug; 61(2):281-93. PubMed ID: 19615539
[TBL] [Abstract][Full Text] [Related]
9. Poly-L-lactic acid: a new dimension in soft tissue augmentation.
Rotunda AM; Narins RS
Dermatol Ther; 2006; 19(3):151-8. PubMed ID: 16784514
[TBL] [Abstract][Full Text] [Related]
10. Poly-L-lactic acid injection for HIV-associated facial lipoatrophy: treatment principles, case studies, and literature review.
Kates LC; Fitzgerald R
Aesthet Surg J; 2008; 28(4):397-403. PubMed ID: 19083552
[TBL] [Abstract][Full Text] [Related]
11. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
Lam SM; Azizzadeh B; Graivier M
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
[TBL] [Abstract][Full Text] [Related]
12. Facial volumetric correction with injectable poly-L-lactic acid.
Vleggaar D
Dermatol Surg; 2005 Nov; 31(11 Pt 2):1511-7; discussion 1517-8. PubMed ID: 16416633
[TBL] [Abstract][Full Text] [Related]
13. Autologous fat grafting and injectable dermal fillers for human immunodeficiency virus-associated facial lipodystrophy: a comparison of safety, efficacy, and long-term treatment outcomes.
Shuck J; Iorio ML; Hung R; Davison SP
Plast Reconstr Surg; 2013 Mar; 131(3):499-506. PubMed ID: 23142937
[TBL] [Abstract][Full Text] [Related]
14. Recommendations on the Use of Injectable Poly-L-Lactic Acid for Skin Laxity in Off-Face Areas.
Haddad A; Menezes A; Guarnieri C; Coimbra D; Ribeiro E; Sarubi J; Avelar LE; Del Nero MP; da Cunha MG; Mazzuco R; Kamamoto C; Cazerta C
J Drugs Dermatol; 2019 Sep; 18(9):929-935. PubMed ID: 31524350
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles.
Narins RS; Baumann L; Brandt FS; Fagien S; Glazer S; Lowe NJ; Monheit GD; Rendon MI; Rohrich RJ; Werschler WP
J Am Acad Dermatol; 2010 Mar; 62(3):448-62. PubMed ID: 20159311
[TBL] [Abstract][Full Text] [Related]
16. European expert recommendations on the use of injectable poly-L-lactic acid for facial rejuvenation.
Alessio R; Rzany B; Eve L; Grangier Y; Herranz P; Olivier-Masveyraud F; Vleggaar D
J Drugs Dermatol; 2014 Sep; 13(9):1057-66. PubMed ID: 25226006
[TBL] [Abstract][Full Text] [Related]
17. Injectable poly-L-lactic acid for human immunodeficiency virus-associated facial lipoatrophy: cumulative year 2 interim analysis of an open-label study (FACES).
Bassichis B; Blick G; Conant M; Condoluci D; Echavez M; Eviatar J; Gold MH; Hamilton T; Hanke CW; Humble G; LaMarca A; Daro-Kaftan E; Mest D; Pierone G
Dermatol Surg; 2012 Jul; 38(7 Pt 2):1193-205. PubMed ID: 22759256
[TBL] [Abstract][Full Text] [Related]
18. Soft-tissue augmentation and the role of poly-L-lactic acid.
Vleggaar D
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):46S-54S. PubMed ID: 16936544
[TBL] [Abstract][Full Text] [Related]
19. The "skinny"on Sculptra: a practical primer to volumization with poly-L-lactic acid.
Palm M; Chayavichitsilp P
J Drugs Dermatol; 2012 Sep; 11(9):1046-52. PubMed ID: 23135646
[TBL] [Abstract][Full Text] [Related]
20. Retreatment with injectable poly-l-lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific study.
Mest DR; Humble GM
Dermatol Surg; 2009 Feb; 35 Suppl 1():350-9. PubMed ID: 19207325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
